Home/Pipeline/ADI‑PEG20

ADI‑PEG20

ASS1‑deficient solid tumors

Phase 2Active

Key Facts

Indication
ASS1‑deficient solid tumors
Phase
Phase 2
Status
Active
Company

About Bioprofarma Bago

Latin biotech delivering oncology and specialty medicines across Latin America through manufacturing and strategic partnerships.

View full company profile